Chronic HCV infection has been linked to lymphoproliferative disorders. Can early PegIFN/RBV therapy reduce the risk? Alimentary Pharmacology & Therapeutics
Original Article: Early Antiviral Therapy and Lymphoma Risk in Chronic HCV